NEAL KLEIMAN to Fibroblast Growth Factor 2
This is a "connection" page, showing publications NEAL KLEIMAN has written about Fibroblast Growth Factor 2.
Connection Strength
0.050
-
Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation. 2002 Feb 19; 105(7):788-93.
Score: 0.050